At Berkshire Hathaway’s closing price on Friday, November 1 of $323,400, and its book value of $243,484 at the end of the third quarter, its price to book value ratio = 1.33, which is 16% below its 30 year average of 1.58.
David I Kass
Clinical Associate Professor, Department of Finance
Ph.D., Harvard University
Robert H. Smith School of Business
4412 Van Munching Hall
University of Maryland
College Park, MD 20742-1815
Phone: 301-405-9683
Email: dkass@rhsmith.umd.edu (link sends e-mail)
Dr. David Kass has published articles in corporate finance, industrial organization, and health economics. He currently teaches Advanced Financial Management and Business Finance, and is the Faculty Champion for the Accelerated Finance Fellows. Prior to joining the faculty of the Smith School in 2004, he held senior positions with the Federal Government (Federal Trade Commission, General Accounting Office, Department of Defense, and the Bureau of Economic Analysis). Dr. Kass has recently appeared on Bloomberg TV, CNBC, PBS Nightly Business Report, Maryland Public Television, Business News Network TV (Canada), Fox TV, American Public Media's Marketplace Radio, and WYPR Radio (Baltimore), and has been quoted on numerous occasions by Bloomberg News and The Wall Street Journal, where he has primarily discussed Warren Buffett and Berkshire Hathaway. He has also launched a Smith School “Warren Buffett” blog. Dr. Kass has accompanied MBA students on trips to Omaha for private meetings with Warren Buffett, and Finance Fellows to Berkshire Hathaway’s annual meetings. He is an officer of the Harvard Business School Club of Washington, DC, and is a member of the investment and budget committees of a local nonprofit organization. Dr. Kass received a Smith School “Top 15% Teaching Award” for the 2009-2010 academic year.
Brevan Howard's flagship Master Fund was down 1.9 percent in the month of August, and returns for the year are up in the neighborhood of +1 percent for the... read more
Glaucus Research Group California LLC is Short Altisource Asset Management Corp (NYSE:AAMC) and Long Altisource Residential Corp (NYSE:RESI)
A video parody of this Investment Research Report can be viewed here.
SHORT: ALTISOURCE ASSET MANAGEMENT CORP... read more
The numbers below do not take into account Exxon restarting Baytown very soon that will take another 600,000bbl/day off the market.
Q2 hedge fund letters, conference, scoops etc
“Davidson” submits:
US Crude... read more
The Year of the IPO continues! We wrote about the parallels between Pinterest and early Facebook, we did an extensive Slack S-1 read-through, and we highlighted what Uber and... read more
Caught on Tape: Herbalife (NYSE:HLF) Cures Brain Tumor? reposted with permission ABC News/Brian Ross, Matthew Mosk, Rym Momtaz and William Gallego
By BRIAN ROSS, MATTHEW MOSK, RYM MOMTAZ and WILLIAM GALLEGO
http://abcnews.go.com/Blotter/caught-tape-herbalife-cures-brain-tumor/story?id=23441488
Nearly... read more
Barclays is out with a new note regarding the Senate banking committee proposal to wind-down Fannie Mae / Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) and Freddie Mac / Federal... read more
Over the past few decades, the central banks, including the Federal Reserve (Fed), have relied increasingly on interest rates to help modify economic growth. Interest rate management is their... read more
While value investors by their very nature, should not believe in the efficient market hypothesis, it’s always interesting to see what trends researchers are discovering about the wider market,... read more
The Great Recession undoubtedly shook the financial landscape; even today, the events leading up to the recession and the recession itself continue to play a role in the creation... read more
For profit education companies have been under pressure lately as declining student enrollments across the country stand to impact the entire sector.
As if this was not enough, the government... read more
Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:
Learn from the best and forever change your investing perspective
One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.
Congrats! Are you a smart person?
We have an exclusive targeted for being a sophisticated and loyal reader.
Sign up for ValueWalkPremium today and get our exclusive content for 35% off.
Limited time offer only ENDS 12/31/2019 or after next 25 subscribers take advantage whichever comes first – please do not share this discount with others